Payer Perspectives on Risk Sharing Deals

Payer Perspectives on Risk Sharing Deals

Code: FW-20150304 | Published: Mar-2015 | Pages: - | FirstWord
Price :
$595.00
USD

* Required Fields

$595.00

Details




Risk sharing agreements have been a strategic tool employed for more than a decade. Yet, theyre still widely misunderstood - and underutilized, especially as they may help provide access to a frugal, risk-averse marketplace.

Are you up to speed on all that a risk sharing agreement might do for your product or organization?

Payer Perspectives on Risk Sharing offers expert insights on how risk sharing agreements can be a win-win for both pharmaceutical companies and payers in helping to build relationships and achieve optimal market access. In addition, gain perspective on when and how the right risk sharing agreement can help your product succeed in the marketplace.







Key Benefits

- Critical insights from US and EU payers and market access experts
- Learn about the various types of risk sharing agreements
- Understand what payers want from risk sharing agreements
- Assess how risk sharing agreements impact market access and price
- Determine when it makes sense for a company to propose a risk sharing agreement
- Master how to build a risk sharing agreement that will work for you



Answers to Critical Questions
Filled with charts and up-to-the-minute survey analysis, this report offers:

- What are the advantages and disadvantages of risk sharing agreements for companies?
- What do payers see as the advantages and disadvantages of risk sharing agreements?
- How might a risk sharing agreement help your product succeed in todays marketplace?
- What will a payer want from you in a risk sharing agreement?
- How much "risk" is actually shared in a risk sharing agreement?
- What support do payers offer companies considering risk sharing schemes?


Top Takeaways

- Insights into the viability of risk sharing agreements in the US and EU5
- A wide-ranging review and analysis of the available literature and media coverage of risk sharing agreements
- In-depth interviews with both payers and the experts who are shaping their views on risk sharing agreements
- Structure and anatomy of various types of risk sharing agreements
- The pros and cons of risk sharing agreements for both companies and payers


Experts Interviewed


- Officer for Pharmaceutical Policy, Italian Medicines Agency (Agenzia Italiana del Farmaco; AIFA), Italy
- Pharmacy Director of a Prescription Benefit Management subsidiary of a major US health care company
- External advisor to the Transparency Commission and Guidelines Committee in France
- Expert from Osteba (Basque Office for HTA), Spain
- Professor from Andalusian School of Public Health, Spain
- Pharmacy Lead, Specialised Services, NHS England, England
- Medical Director of a US integrated health services organisation
- Programme Director Technology Appraisals, Highly Specialised Technologies and the Patient Access Schemes Liaison Unit at the National Institute for Health and Care Excellence (NICE), England
- Pharmacy Director of US Managed Care Organisation (1)
- Pharmacy Director of US Managed Care Organisation (2)
- Health Economist, A Gemelli Teaching Hospital, Italy
- Health Economist, France



About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

- FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your companys success.
- FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.

Learn more at www.firstwordgroup.com.


Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
FirstWord